Skip to main content

MoneyWorks4Me

Gujarat Themis Biosyn gets nod to raise Rs 585 crore via NCDs

11 Sep 2026 Evaluate

Gujarat Themis Biosyn has received approval for the issuance of Non-Convertible Debentures (NCDs) aggregating upto Rs 585 crore on private placement basis. The Board of Directors of the Company at its meeting held on September 10, 2026, has inter-alia considered and approved the same. 

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company.


Peers
Company Name CMP
Sun Pharma. Inds. 1757.20
Dr. Reddys Labs. 1340.15
Cipla 1357.70
Lupin 1987.50
Zydus Lifesciences 1174.10
View more..